Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman’s Latest Analysis on Emicizumab
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
This study used mathematical modeling and biochemical assays to dissect how emicizumab, a bispecific antibody bridging activated factor IXa and factor X, functions differently from factor VIII.
It revealed that high emicizumab levels inhibit factor X activation via tissue factor pathway due to reduced lipid surface binding but enhance factor IXa-dependent activation of factor X on lipid surfaces.
The model provides kinetic estimates and explains emicizumab’s mechanism of enhancing coagulation through lipid-surface interactions.
Read this paper.
Authors: Jamie Madrigal, Dougald Monroe, Suzanne Sindi, Karin Leiderman”
Read the full article in JTH.
Article: Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
Authors: Jamie Madrigal, Dougald Monroe, Suzanne Sindi, Karin Leiderman
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera